Evidence map›Paper›PMID 29500627›Full record

ArticleJournal of genetic counseling2018

Parkinson's Disease: Patients' Knowledge, Attitudes, and Interest in Genetic Counseling.

Kristin A Maloney, Dina S Alaeddin, Rainer von Coelln, Shannan Dixon, Lisa M Shulman, Katrina Schrader, Yue Guan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of genetic counseling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Does genetic testing remain relevant in advanced Parkinson's disease?Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Genetic Testing of Movements Disorders: A Review of Clinical Utility.Tremor and other hyperkinetic movements (New York, N.Y.) · 2024
    Review
  11. Article
  12. Article
  13. Genetic Testing in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2023
    Article
  14. Article
  15. Article
  16. The Role of Genetic Testing for Parkinson's Disease.Current neurology and neuroscience reports · 2021
    Review
  17. Genetic Testing for Parkinson Disease: Are We Ready?Neurology. Clinical practice · 2021
    Review
  18. Experience in Genetic Counseling forMovement disorders clinical practice · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kristin A MaloneyDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Dina S AlaeddinInova Translational Medicine Institute, Falls Church, VA, USA.
Rainer von CoellnDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
Shannan DixonDepartment of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.
Lisa M ShulmanDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
Katrina SchraderDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
Yue GuanDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. yguan@medicine.umaryland.edu.ORCID 0000-0001-8521-1859
University of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to assess the genetics knowledge of patients with Parkinson's disease (PD), and to explore their attitudes on genetic testing and interest in genetic counseling. We surveyed 158 patients from the University of Maryland Parkinson's Disease and Movement Disorders Center. Patients averaged a score of 63% on general genetics knowledge and 73% on PD genetics knowledge. Participants had an overall positive attitude toward genetic testing: 80% believed that the use of genetic tests among people should be promoted, and 83% would undertake genetic test for PD if it was available. Patients reported a high interest to discuss the benefits, risks, and impacts of genetic testing for PD (mean sum score = 26, range = 9-35), and 43% patients expressed interest in meeting with a genetic counselor. Multivariate regression analysis showed that patients who had more positive attitudes toward genetic testing for PD were more interested in meeting with a genetic counselor (β = 0.6, p < 0.001). This study is the first to demonstrate an interest in genetic counseling among patients with PD. Our findings demonstrate a new niche for genetic counselors to support patients in clarifying gaps or misconceptions in knowledge about PD genetics as well as the possible risks, benefits, and limitations of genetic testing.

Indexed as

Health Knowledge, Attitudes, PracticeAdultFemaleGenetic CounselingGenetic TestingHumansMaleMiddle AgedParkinson DiseaseQuality of LifeAttitudesGenetic counselingGenetic testingKnowledgeParkinson’s disease

Identifiers

PMID29500627
OpenAlexW2789563481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.